Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors

Molecular and Cellular Endocrinology

Volumn 141, Issue 1-2, 1998, Pages 53-64

  Ram, P T ^a   Kiefer, T ^a   Silverman, M ^b   Song, Y ^b   Brown, G M ^b   Hill, S M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Epidermal growth factor; Estrogen receptor; Melatonin

Indexed keywords

ANTIESTROGEN; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; LUCIFERASE; MELATONIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PINEAL BODY HORMONE;

ARTICLE; ASSAY; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GROWTH SUBSTANCES; HUMANS; INSULIN; MELATONIN; PERTUSSIS TOXIN; PHOSPHORYLATION; POLYUNSATURATED ALKAMIDES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, MELATONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0032565919     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00095-1     Document Type: Article

References (33)

1. Ali S., Metzger D., Bornet J-M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
2. Arnold S.F., Obourn J.D., Yudt M.R., Carter T.H., Notides A.C. In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol. 52:1995;159-171.
3. Aronica S.M., Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor. Mol. Endocrinol. 7:1993;743-752.
4. Bartsch C., Bartsch H., Jain A.K., Laumas K.R., Watterberg L. Urinary melatonin levels in human breast cancer patients. J. Neural Trans. 52:1981;269-279.
5. Blask D.E., Hill S.M. Effects of melatonin on cancer, studies on MCF-7 human breast cancer cells in culture. J Neural Trans. 29:1986;406-412.
6. Blask D.E., Hill S.M., Orstead K.M., Massa J.S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracine (DMBA)-induced mammary tumorigenesis. J. Neural Trans. 67:1986;125-138.
7. Burns D.M., Cos C.S., Blask D., 1990. Demonstration of partial characterization of 2-iodomelatonin binding sites in experimental mammary carcinoma. Program of the 72nd Annual Meeting of the Endocrine Society, San Antonio, TX. p.62 (Abs).
8. Cos, S., Blask, D.E., Lemus-Wilson, A., Hill, S.M., 1991. Effects of melatonin on the cell cycle kinetics and 'estrogen-rescue' of MCF-7 human breast cancer cells in culture. J. Pineal Res. 8;21-27.
9. Danforth D.N., Tamarkin L., Lippman M.E. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature. 305:1983;323-325.
10. Ebisawa T., Karne S., Lerner M.R., Reppert S.M. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl. Acad. Sci. USA. 91:1994;6133-6137.
11. 1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology. 138:1997;397-404.
12. Hafner F., Holler E., von Angerer E. Effect of growth factors on estrogen receptor mediated gene expression. J. Steroid Biochem. Mol. Biol. 58:1996;385-393.
13. Hazelrigg D.G., Thompson M., Hastings M.H., Morgan P.J. Regulation of mitogen-activated protein kinase in the pars tuberalis of ovine pituitary, interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology. 137:1996;210-218.
14. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and the morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.
15. Hill S.M., Spriggs L.L., Simon M.A., Muraoka H., Blask D.E. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Letters. 64:1992;249-256.
16. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotch Y., Nishide E., Chambon P. Activation of the estrogen receptor through phosphorylation by the mitogen activated protein kinase. Science. 270:1995;1491-1494.
17. Klein-Hitpass L., Schorpp M., Wagner U., Ryffel G.U. An estrogen-responsive element derived from the 5′-flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 46:1986;1053-1061.
18. Le Goff P., Montano M.M., Shodin D.J., Katzenellenbogen B.S. Phosphorylation of the human estrogen receptor. J. Biol. Chem. 269:1994;4458-4466.
19. βγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activity. J. Biol. Chem. 272:1997;4637-4644.
20. McNulty, S., Morgan, P.J., Thompson, M., Davidson, G., Lawson, N., Hastings, MH., 1994a. Phospholipases and melatonin signal transduction in the ovine pars tuberalis. Mol. Cell. Endo. 99;73-79.
21. McNulty S., Ross A.W., Barrett P., Hastings M.H., Morgan P.J. Melatonin regulates the phosphorylation of CREB in Ovine pars tuberalis. J. Neuroendo. 6:1994;523-532.
22. Molis T.M., Walters M.R., Hill S.M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int. J. Oncol. 3:1993;687-694.
23. Molis T.M., Spriggs L.L., Hill S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1994;1681-1690.
24. Molis T.M., Spriggs L.L., Jupiter Y., Hill S.M. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J. Pineal Res. 18:1995;93-103.
25. Morgan P.J., Perry B., Edward H.H., Helliwell R., Sugden D. Melatonin receptors, localization, molecular pharmacology and physiological significance. Neurochem. Int. 24:1994;101-146.
26. Pace A.M., Faure M., Bourne H.R. Gil-mediated activation of the MAP kinase cascade. Mol. Biol. Cell. 6:1995;1685-1695.
27. Reiter R.J. Neuroendocrinology of melatonin. Miles A., Philbreck D.R., Thompson C. Melatonin, Clinical Perspectives. 1988;1-42 Oxford University Press, New York.
28. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron. 13:1994;1177-1185.
29. 1a subtype localized primarily to the basolateral membrane of the proximal tubule. FASEB J. 11:1997;93-100.
30. Tapp E. The pineal gland in malignancy. Reiter R.J. The Pineal Gland, Vol 3. 1982;171-188 CRC Press, Boca Raton.
31. Thompson E.W., Katz D., Shima T.B., Wakeling A.E., Lippman M.E., Dickson R.B. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res. 49:1989;6929-6934.
32. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.B., Pike J.W., McDonnell D.P. Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 9:1994;21-30.
33. Vanecek J. Melatonin inhibits increase of intracellular calcium and cyclic AMP in neonatal rat pituitary via independent pathways. Mol. Cell. Endocrinol. 107:1995;149-153.